May 21, 2026 06:36AM
May 21, 2026 05:19AM
May 20, 2026 11:50AM
May 20, 2026 07:04AM
May 20, 2026 07:03AM
Apr 2, 2026 11:58AM
Apr 2, 2026 11:16AM Immunovant (IMVT) PT Lowered to $50 at Leerink Partners
Apr 2, 2026 10:15AM
Apr 2, 2026 06:54AM
Mar 20, 2026 08:38AM
Mar 20, 2026 08:38AM
Feb 6, 2026 07:05AM
Jan 26, 2026 03:29PM
Jan 6, 2026 05:34AM Wolfe Research Upgrades Immunovant (NASDAQ: IMVT) to Outperform (correction)
Dec 11, 2025 03:58AM
Nov 21, 2025 08:05AM
Nov 11, 2025 05:57AM
Nov 10, 2025 07:32AM
Oct 14, 2025 06:06AM
Sep 4, 2025 06:24AM
Sep 3, 2025 12:58PM Immunovant reports durability data for Graves' disease drug candidate
Aug 11, 2025 12:19PM
Aug 11, 2025 11:44AM
Aug 11, 2025 11:02AM
Jul 25, 2025 07:34AM
Jul 10, 2025 06:29AM
May 30, 2025 06:41AM
Apr 21, 2025 07:02AM Immunovant (IMVT) Announces Leadership Changes
Mar 20, 2025 12:01PM
Mar 20, 2025 06:39AM
Mar 20, 2025 06:35AM
Mar 20, 2025 06:07AM
Mar 19, 2025 07:45AM
Mar 3, 2025 04:14AM
Feb 25, 2025 06:59AM Piper Sandler: 'This Is the Right Time to Own Immunovant (IMVT) and Here Is Why'
Feb 10, 2025 07:28AM
Feb 10, 2025 06:40AM
Jan 23, 2025 05:01AM
Jan 13, 2025 08:01AM
Jan 3, 2025 08:23AM
Dec 30, 2024 05:23PM
Oct 10, 2024 08:21AM Raymond James Resumes Immunovant (IMVT) at Outperform
Oct 9, 2024 06:10AM
Sep 30, 2024 07:25AM
Sep 25, 2024 08:22AM
Sep 12, 2024 07:46AM
Sep 10, 2024 06:40AM
Sep 9, 2024 02:33PM
Sep 9, 2024 01:22PM BofA Securities Reiterates Buy Rating on Immunovant (IMVT), PT $49, 'catalyst-rich 1H25'
Sep 9, 2024 11:56AM

416,816 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All